DOTA-cyclo(RGDfK)，RGD肽指含有由Arg-Gly-Asp三個氨基酸組成的序列多肽

試劑基團反應特點（Reagent group reaction characteristics）：
DOTA-cyclo(RGDfK)螯合劑多肽，RGD肽是指含有由Arg-Gly-Asp三個氨基酸組成的序列多肽，有直線肽和環肽之分。它們是許多細胞外基質蛋白（如VN、FN、FGN、膠原等）等小識別短肽序列。RGD作為某些整合素的受體，其選擇性部分依賴于RGD的構象以及RGD周圍的氨基酸殘基。
DOTA cycle (RGDfK) chelating agent peptide, RGD peptide refers to a sequence peptide composed of Arg Gly Asp three amino acids, which can be divided into linear peptide and cyclic peptide. They are small recognition short peptide sequences of many extracellular matrix proteins (such as VN, FN, FGN, collagen, etc.). As a receptor for certain integrins, the selectivity of RGD partially depends on the conformation of RGD and the amino acid residues around RGD.
基礎產品數據（Basic Product Data）：
CAS號：N/A
英文名：DOTA-cyclo(RGDfK)，DOTA-c(RGDfK)
結構式（Structural）：

詳細產品數據（Detailed Product Data）：
Molecular formula：C43H67N13O14
Molecular weight：989.09
Purity standard：95%+，具體的試劑可以在線進行咨詢
Storage conditions：At 20 ℃, in a cool, dry and well ventilated warehouse
Packaging specification：1g、5g、10g等（Customized packaging will be carried out according to the situation）
Solubility：Soluble in most organic solvents, such as DCM, DMF, DMSO, THF, etc., with good solubility in water）
In stock：SCommunicate with suppliers
Precautions：Keep a dry environment when using, and avoid frequent thawing for freezing.
試劑系列產品（Reagent series products）：
Cyclo(-Hyp-Gly)
CTTHWGFTLC, CYCLIC
1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid(ACI)
(R)-tert-Bu4-DOTAGA
FAPI-4-NH2
PSMA I&T,DOTAGA-DTyr(3I)-DPhe-DLys(Sub-Lys-urea-Glu)
FAP-2286
DOTA-E-[cyclo(RGDfK(Acp))]2
cyclo(RGDFK(DOTA)）
Cyclo[(D-Tyr)-(D-NMe-Orn)-Arg-(2-Nal)-Gly] [Cyclo(D-Tyr)
DOTA-cyclo(RGDfK) acetate
DOTA-cyclo(RGDyK)
DOTA-E[c(RGDfK)2]
DOTA-cyclo(RGDfK)
DOTA-E[c(RGDyK)2]
Exendin-4
DOTA-MeTz  DOTA-甲基四嗪
DOTA-DBCO
DOTA-PEG4-MeTz   DOTA-四聚乙二醇-甲基四嗪
DOTA-PEG5-DBCO
DOTA-PEG5-azide
溫馨提示：所有的試劑僅用于科研實驗。
今日分享的文章包含DOTA-cyclo(RGDfK)試劑相關物理數據，化學式，CAS號，反應特點，以及相應的結構式，有相關疑問的朋友，歡迎關注收藏，為大家答疑解惑，進行交流。

供應商：西安凱新生物科技有限公司

請點擊西安凱新生物科技有限公司展臺進入查看

請點擊西安凱新生物科技有限公司展臺進入查看